864 related articles for article (PubMed ID: 17802940)
1. [Neuropsychiatric manifestations in systemic lupus erythematosus].
Alexa ID; Stoica MS; Paraschiv O; Rusu RI
Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):322-5. PubMed ID: 17802940
[TBL] [Abstract][Full Text] [Related]
2. Echolalia as a novel manifestation of neuropsychiatric systemic lupus erythematosus.
Zapor M; Murphy FT; Enzenauer R
South Med J; 2001 Jan; 94(1):70-2. PubMed ID: 11213948
[TBL] [Abstract][Full Text] [Related]
3. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.
Sibbitt WL; Brandt JR; Johnson CR; Maldonado ME; Patel SR; Ford CC; Bankhurst AD; Brooks WM
J Rheumatol; 2002 Jul; 29(7):1536-42. PubMed ID: 12136916
[TBL] [Abstract][Full Text] [Related]
4. Antibodies in patients with neuropsychiatric systemic lupus erythematosus.
Kimura A; Kanoh Y; Sakurai T; Koumura A; Yamada M; Hayashi Y; Tanaka Y; Hozumi I; Takemura M; Seishima M; Inuzuka T
Neurology; 2010 Apr; 74(17):1372-9. PubMed ID: 20421581
[TBL] [Abstract][Full Text] [Related]
5. [Initial manifestation by cerebral vasculitis in systemic lupus erythematosus].
Mrabet D; Meddeb N; Sahli H; Rammeh N; Sellami S
Tunis Med; 2008 Jun; 86(6):618-9. PubMed ID: 19216467
[No Abstract] [Full Text] [Related]
6. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
Mikdashi J; Handwerger B
Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927
[TBL] [Abstract][Full Text] [Related]
7. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
[TBL] [Abstract][Full Text] [Related]
8. Psychiatric manifestations in systemic lupus erythematosus.
Stojanovich L; Zandman-Goddard G; Pavlovich S; Sikanich N
Autoimmun Rev; 2007 Jun; 6(6):421-6. PubMed ID: 17537389
[TBL] [Abstract][Full Text] [Related]
9. [Neuropsychiatric involvement in systemic lupus erythematosus. Part 1: clinical presentation and pathogenesis].
Weiner SM; Peter HH
Med Klin (Munich); 2002 Dec; 97(12):730-7. PubMed ID: 12491066
[TBL] [Abstract][Full Text] [Related]
10. Use of aripiprazole in adolescents with a history of lupus-associated psychosis and refractory psychiatric manifestations.
Muscal E; Bang L; Mian A; Harris TB
J Psychiatr Pract; 2011 May; 17(3):212-6. PubMed ID: 21587001
[TBL] [Abstract][Full Text] [Related]
11. Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India.
Seth G; Sundaresh A; Mariaselvam CM; Kumar G; Chengappa KG; Adarsh MB; Tamouza R; Negi VS
Lupus; 2020 Apr; 29(4):413-420. PubMed ID: 32106787
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of neuro-reactive autoantibodies in neuro-psychiatric systemic lupus erythematosus].
Lu XY; Ye S; Wang Y; Guo L; Chen XX; Fan W; Wang XD; Gu YY; Bao CD; Liu Q
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2462-6. PubMed ID: 17156673
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.
Sanna G; Bertolaccini ML; Cuadrado MJ; Laing H; Khamashta MA; Mathieu A; Hughes GR
J Rheumatol; 2003 May; 30(5):985-92. PubMed ID: 12734893
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
Mok CC; Lau CS; Wong RW
J Rheumatol; 2001 Apr; 28(4):766-71. PubMed ID: 11327248
[TBL] [Abstract][Full Text] [Related]
16. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus.
Baca V; Lavalle C; García R; Catalán T; Sauceda JM; Sánchez G; Martínez I; Ramírez ML; Márquez LM; Rojas JC
J Rheumatol; 1999 Feb; 26(2):432-9. PubMed ID: 9972981
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychiatric systemic lupus erythematosus among Nigerians.
Adelowo OO; Oguntona AS; Ojo O
Afr J Med Med Sci; 2009 Mar; 38(1):33-8. PubMed ID: 19722426
[TBL] [Abstract][Full Text] [Related]
18. Fulminant onset of cerebral immunocomplex vasculitis as first manifestation of neuropsychiatric systemic lupus erythematosus (NPSLE).
Rizos T; Siegelin M; Hähnel S; Storch-Hagenlocher B; Hug A
Lupus; 2009 Apr; 18(4):361-3. PubMed ID: 19276305
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE).
Hermosillo-Romo D; Brey RL
Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):229-44. PubMed ID: 12041951
[TBL] [Abstract][Full Text] [Related]
20. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
